Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 379 entries
Sorted by: Best Match Show Resources per page
Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients?.

International journal of clinical and experimental medicine

Yasar Z, Kirakli C, Cimen P, Ucar ZZ, Talay F, Tibet G.
PMID: 26309710
Int J Clin Exp Med. 2015 Jun 15;8(6):10114-21. eCollection 2015.

INTRODUCTION: Non-thyroidal illness syndrome (NTIS) is considered to be associated with adverse outcomes in intensive care unit (ICU) patients. In this study, we evaluated the association between NTIS and prolonged weaning in chronic obstructive pulmonary disease (COPD) patients admitted...

Cite
Yasar Z, Kirakli C, Cimen P, et al. Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients?. Int J Clin Exp Med. 2015;8(6):10114-21
Yasar, Z., Kirakli, C., Cimen, P., Ucar, Z. Z., Talay, F., & Tibet, G. (2015). Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients?. International journal of clinical and experimental medicine, 8(6), 10114-21.
Yasar, Zehra, et al. "Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients?." International journal of clinical and experimental medicine vol. 8,6 (2015): 10114-21.
Yasar Z, Kirakli C, Cimen P, Ucar ZZ, Talay F, Tibet G. Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients?. Int J Clin Exp Med. 2015 Jun 15;8(6):10114-21. eCollection 2015. PMID: 26309710; PMCID: PMC4538104.
Copy Download .nbib Format: NLM
An Unusual Reason for Gastric Variceal Hemorrhage: Wandering Spleen.

The Indian journal of surgery

Köseoğlu H, Atalay R, Büyükaşık NŞ, Canyiğit M, Özer M, Solakoğlu T, Akın FE, Bolat AD, Yürekli ÖT, Ersoy O.
PMID: 26730110
Indian J Surg. 2015 Dec;77:750-1. doi: 10.1007/s12262-013-0993-2. Epub 2013 Oct 19.

Wandering spleen is the displacement of the spleen due to the loss or weakening of the ligaments of the spleen and is seen very rarely with an incidence of less than 0.5 %. It can cause portal hypertension, but...

Cite
Köseoğlu H, Atalay R, Büyükaşık NŞ, et al. An Unusual Reason for Gastric Variceal Hemorrhage: Wandering Spleen. Indian J Surg. 2013;77:750-1doi: 10.1007/s12262-013-0993-2.
Köseoğlu, H., Atalay, R., Büyükaşık, N. �. �., Canyiğit, M., Özer, M., Solakoğlu, T., Akın, F. E., Bolat, A. D., Yürekli, �. �. T., & Ersoy, O. (2015). An Unusual Reason for Gastric Variceal Hemorrhage: Wandering Spleen. The Indian journal of surgery, 77750-1. https://doi.org/10.1007/s12262-013-0993-2
Köseoğlu, Hüseyin, et al. "An Unusual Reason for Gastric Variceal Hemorrhage: Wandering Spleen." The Indian journal of surgery vol. 77 (2015): 750-1. doi: https://doi.org/10.1007/s12262-013-0993-2
Köseoğlu H, Atalay R, Büyükaşık NŞ, Canyiğit M, Özer M, Solakoğlu T, Akın FE, Bolat AD, Yürekli ÖT, Ersoy O. An Unusual Reason for Gastric Variceal Hemorrhage: Wandering Spleen. Indian J Surg. 2015 Dec;77:750-1. doi: 10.1007/s12262-013-0993-2. Epub 2013 Oct 19. PMID: 26730110; PMCID: PMC4692925.
Copy Download .nbib Format: NLM
First observation of Hb Tunis [beta124(H2)Pro>Ser] in Turkey.

Turkish journal of haematology : official journal of Turkish Society of Haematology

Köseler A, Koyuncu H, Öztürk O, Bahadır A, Demirtepe S, Atalay A, Ömer Atalay E.
PMID: 27263455
Turk J Haematol. 2010 Jun 05;27(2):120-2. doi: 10.5152/tjh.2010.11.

Hb Tunis [beta124(H2)Pro>Ser] was reported from Tunisia in 1988. This hemoglobin variant was detected by isoelectric focusing moving just ahead of Hb A. It cannot be identified by standard hemoglobin electrophoresis due to its similar mobility to Hb A....

Cite
Köseler A, Koyuncu H, Öztürk O, et al. Türkiye'de gözlenen ilk Hb Tunis [beta124(H2)Pro>Ser] olgusu. First observation of Hb Tunis [beta124(H2)Pro>Ser] in Turkey. Turk J Haematol. 2010;27(2):120-2doi: 10.5152/tjh.2010.11.
Köseler, A., Koyuncu, H., Öztürk, O., Bahadır, A., Demirtepe, S., Atalay, A., & Ömer Atalay, E. (2010). Türkiye'de gözlenen ilk Hb Tunis [beta124(H2)Pro>Ser] olgusu. First observation of Hb Tunis [beta124(H2)Pro>Ser] in Turkey. Turkish journal of haematology : official journal of Turkish Society of Haematology, 27(2), 120-2. https://doi.org/10.5152/tjh.2010.11
Köseler, Aylin, et al. "Türkiye'de gözlenen ilk Hb Tunis [beta124(H2)Pro>Ser] olgusu." First observation of Hb Tunis [beta124(H2)Pro>Ser] in Turkey. Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 27,2 (2010): 120-2. doi: https://doi.org/10.5152/tjh.2010.11
Köseler A, Koyuncu H, Öztürk O, Bahadır A, Demirtepe S, Atalay A, Ömer Atalay E. Türkiye'de gözlenen ilk Hb Tunis [beta124(H2)Pro>Ser] olgusu. First observation of Hb Tunis [beta124(H2)Pro>Ser] in Turkey. Turk J Haematol. 2010 Jun 05;27(2):120-2. doi: 10.5152/tjh.2010.11. PMID: 27263455.
Copy Download .nbib Format: NLM
Mass Effect of Pulmonary Sequestration: Multiloculated-Multiseptated Pneumomediastinum.

Journal of neonatal surgery

Unal S, Türkyılmaz C, Derinkuyu BE, Aktaş S, Ergenekon E, Boyunağa Ö, Atalay Y.
PMID: 27123402
J Neonatal Surg. 2016 Apr 10;5(2):18. eCollection 2016.

Pulmonary sequestration (PS) and pneumomediastinum are two rare clinical diseases. Pneumomediastinum was generally observed in infants either with diseased lungs or who were performed assisted ventilation or resuscitation following birth. It was reported in patients with existing ectopic thoracic...

Cite
Unal S, Türkyılmaz C, Derinkuyu BE, et al. Mass Effect of Pulmonary Sequestration: Multiloculated-Multiseptated Pneumomediastinum. J Neonatal Surg. 2016;5(2):18
Unal, S., Türkyılmaz, C., Derinkuyu, B. E., Aktaş, S., Ergenekon, E., Boyunağa, �. �., & Atalay, Y. (2016). Mass Effect of Pulmonary Sequestration: Multiloculated-Multiseptated Pneumomediastinum. Journal of neonatal surgery, 5(2), 18.
Unal, Sezin, et al. "Mass Effect of Pulmonary Sequestration: Multiloculated-Multiseptated Pneumomediastinum." Journal of neonatal surgery vol. 5,2 (2016): 18.
Unal S, Türkyılmaz C, Derinkuyu BE, Aktaş S, Ergenekon E, Boyunağa Ö, Atalay Y. Mass Effect of Pulmonary Sequestration: Multiloculated-Multiseptated Pneumomediastinum. J Neonatal Surg. 2016 Apr 10;5(2):18. eCollection 2016. PMID: 27123402; PMCID: PMC4841374.
Copy Download .nbib Format: NLM
Effect of α-Tocopherol on Lipid Peroxidation Caused by Cisplatin in Rat Kidney.

Turkish journal of haematology : official journal of Turkish Society of Haematology

Bolaman Z, Köseoğlu MH, Demir S, Kadıköylü G, Barutca S, Atalay H, Aslan D.
PMID: 27265333
Turk J Haematol. 2003 Mar 05;20(1):35-8.

Cisplatin (CDDP) is one of the most commonly used antineoplastic agents in current clinical practice. The major toxicities of CDDP are nonhaematological as nephrotoxicity and ototoxicity. Free oxygen radicals are known to play major role in CDDP-induced acute renal...

Cite
Bolaman Z, Köseoğlu MH, Demir S, et al. α-Tokoferolün Sıçan Böbreğinde Sisplatinin Yol Açtığı Lipid Peroksidasyonuna Etkisi. Effect of α-Tocopherol on Lipid Peroxidation Caused by Cisplatin in Rat Kidney. Turk J Haematol. 2003;20(1):35-8
Bolaman, Z., Köseoğlu, M. H., Demir, S., Kadıköylü, G., Barutca, S., Atalay, H., & Aslan, D. (2003). α-Tokoferolün Sıçan Böbreğinde Sisplatinin Yol Açtığı Lipid Peroksidasyonuna Etkisi. Effect of α-Tocopherol on Lipid Peroxidation Caused by Cisplatin in Rat Kidney. Turkish journal of haematology : official journal of Turkish Society of Haematology, 20(1), 35-8.
Bolaman, Zahit, et al. "α-Tokoferolün Sıçan Böbreğinde Sisplatinin Yol Açtığı Lipid Peroksidasyonuna Etkisi." Effect of α-Tocopherol on Lipid Peroxidation Caused by Cisplatin in Rat Kidney. Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 20,1 (2003): 35-8.
Bolaman Z, Köseoğlu MH, Demir S, Kadıköylü G, Barutca S, Atalay H, Aslan D. α-Tokoferolün Sıçan Böbreğinde Sisplatinin Yol Açtığı Lipid Peroksidasyonuna Etkisi. Effect of α-Tocopherol on Lipid Peroxidation Caused by Cisplatin in Rat Kidney. Turk J Haematol. 2003 Mar 05;20(1):35-8. PMID: 27265333.
Copy Download .nbib Format: NLM
Comparison of the cardioprotective effects of dexmedetomidineand remifentanil in cardiac surgery.

Turkish journal of medical sciences

Türktan M, Güneş Y, Yalınız H, Matyar S, Hatipoğlu Z, Güleç E, Göçen U, Atalay A.
PMID: 29151310
Turk J Med Sci. 2017 Nov 13;47(5):1403-1409. doi: 10.3906/sag-1612-130.

Background/aim: Myocardial protection is an important factor of open heart surgery and biological biomarkers (lactate, CKMB, cardiac troponin I, and pyruvate) are used to assess myocardial damage. This study compares the effects of dexmedetomidine and remifentanil on myocardial protection...

Cite
Türktan M, Güneş Y, Yalınız H, et al. Comparison of the cardioprotective effects of dexmedetomidineand remifentanil in cardiac surgery. Turk J Med Sci. 2017;47(5):1403-1409doi: 10.3906/sag-1612-130.
Türktan, M., Güneş, Y., Yalınız, H., Matyar, S., Hatipoğlu, Z., Güleç, E., Göçen, U., & Atalay, A. (2017). Comparison of the cardioprotective effects of dexmedetomidineand remifentanil in cardiac surgery. Turkish journal of medical sciences, 47(5), 1403-1409. https://doi.org/10.3906/sag-1612-130
Türktan, Mediha, et al. "Comparison of the cardioprotective effects of dexmedetomidineand remifentanil in cardiac surgery." Turkish journal of medical sciences vol. 47,5 (2017): 1403-1409. doi: https://doi.org/10.3906/sag-1612-130
Türktan M, Güneş Y, Yalınız H, Matyar S, Hatipoğlu Z, Güleç E, Göçen U, Atalay A. Comparison of the cardioprotective effects of dexmedetomidineand remifentanil in cardiac surgery. Turk J Med Sci. 2017 Nov 13;47(5):1403-1409. doi: 10.3906/sag-1612-130. PMID: 29151310.
Copy Download .nbib Format: NLM
An unusual case of pulmonary nocardiosis in immunocompetent patient.

Case reports in pulmonology

Yaşar Z, Acat M, Onaran H, Ozgül MA, Fener N, Talay F, Cetinkaya E.
PMID: 25506020
Case Rep Pulmonol. 2014;2014:963482. doi: 10.1155/2014/963482. Epub 2014 Nov 17.

Pulmonary nocardiosis is a subacute or chronic necrotizing pneumonia caused by aerobic actinomycetes of the genus Nocardia and rare in immune-competent patients. A 35-year-old male, who had treated with antituberculosis drugs, presented with cough, dyspnea, and expectoration with episodes...

Cite
Yaşar Z, Acat M, Onaran H, et al. An unusual case of pulmonary nocardiosis in immunocompetent patient. Case Rep Pulmonol. 2014;2014:963482doi: 10.1155/2014/963482.
Yaşar, Z., Acat, M., Onaran, H., Ozgül, M. A., Fener, N., Talay, F., & Cetinkaya, E. (2014). An unusual case of pulmonary nocardiosis in immunocompetent patient. Case reports in pulmonology, 2014963482. https://doi.org/10.1155/2014/963482
Yaşar, Zehra, et al. "An unusual case of pulmonary nocardiosis in immunocompetent patient." Case reports in pulmonology vol. 2014 (2014): 963482. doi: https://doi.org/10.1155/2014/963482
Yaşar Z, Acat M, Onaran H, Ozgül MA, Fener N, Talay F, Cetinkaya E. An unusual case of pulmonary nocardiosis in immunocompetent patient. Case Rep Pulmonol. 2014;2014:963482. doi: 10.1155/2014/963482. Epub 2014 Nov 17. PMID: 25506020; PMCID: PMC4251818.
Copy Download .nbib Format: NLM
The impact of weight gain during adjuvant chemotherapy on survival in breast cancer.

Ulusal cerrahi dergisi

Atalay C, Küçük Aİ.
PMID: 26504414
Ulus Cerrahi Derg. 2015 Sep 01;31(3):124-7. doi: 10.5152/UCD.2015.3123. eCollection 2015.

OBJECTIVE: Weight gain can be detected during adjuvant chemotherapy in breast cancer patients, leading to administration of lower drug doses than planned and a decrease in long-term survival. In this study, the effect of weight gain on survival in...

Cite
Atalay C, Küçük Aİ. The impact of weight gain during adjuvant chemotherapy on survival in breast cancer. Ulus Cerrahi Derg. 2015;31(3):124-7doi: 10.5152/UCD.2015.3123.
Atalay, C., & Küçük, A. �. �. (2015). The impact of weight gain during adjuvant chemotherapy on survival in breast cancer. Ulusal cerrahi dergisi, 31(3), 124-7. https://doi.org/10.5152/UCD.2015.3123
Atalay, Can, and Küçük, Ali İmran. "The impact of weight gain during adjuvant chemotherapy on survival in breast cancer." Ulusal cerrahi dergisi vol. 31,3 (2015): 124-7. doi: https://doi.org/10.5152/UCD.2015.3123
Atalay C, Küçük Aİ. The impact of weight gain during adjuvant chemotherapy on survival in breast cancer. Ulus Cerrahi Derg. 2015 Sep 01;31(3):124-7. doi: 10.5152/UCD.2015.3123. eCollection 2015. PMID: 26504414; PMCID: PMC4605106.
Copy Download .nbib Format: NLM
Bronchoalveolar Lavage Fluid Characteristics of Patients With Sarcoidosis and Nonsarcoidosis Interstitial Lung Diseases: Ten-Year Experience of a Single Center in Turkey.

Iranian Red Crescent medical journal

Tanriverdi H, Erboy F, Altinsoy B, Uygur F, Arasli M, Ozel Tekin I, Tor MM, Atalay F.
PMID: 26566455
Iran Red Crescent Med J. 2015 Oct 28;17(10):e31103. doi: 10.5812/ircmj.31103. eCollection 2015 Oct.

BACKGROUND: Bronchoalveolar lavage (BAL) is a noninvasive and useful technique for evaluating interstitial lung diseases (ILDs). Flow cytometric analysis of BAL fluid reveals specific diagnostic information in some unusual ILDs, and helps to narrow down the possible causes of...

Cite
Tanriverdi H, Erboy F, Altinsoy B, et al. Bronchoalveolar Lavage Fluid Characteristics of Patients With Sarcoidosis and Nonsarcoidosis Interstitial Lung Diseases: Ten-Year Experience of a Single Center in Turkey. Iran Red Crescent Med J. 2015;17(10):e31103doi: 10.5812/ircmj.31103.
Tanriverdi, H., Erboy, F., Altinsoy, B., Uygur, F., Arasli, M., Ozel Tekin, I., Tor, M. M., & Atalay, F. (2015). Bronchoalveolar Lavage Fluid Characteristics of Patients With Sarcoidosis and Nonsarcoidosis Interstitial Lung Diseases: Ten-Year Experience of a Single Center in Turkey. Iranian Red Crescent medical journal, 17(10), e31103. https://doi.org/10.5812/ircmj.31103
Tanriverdi, Hakan, et al. "Bronchoalveolar Lavage Fluid Characteristics of Patients With Sarcoidosis and Nonsarcoidosis Interstitial Lung Diseases: Ten-Year Experience of a Single Center in Turkey." Iranian Red Crescent medical journal vol. 17,10 (2015): e31103. doi: https://doi.org/10.5812/ircmj.31103
Tanriverdi H, Erboy F, Altinsoy B, Uygur F, Arasli M, Ozel Tekin I, Tor MM, Atalay F. Bronchoalveolar Lavage Fluid Characteristics of Patients With Sarcoidosis and Nonsarcoidosis Interstitial Lung Diseases: Ten-Year Experience of a Single Center in Turkey. Iran Red Crescent Med J. 2015 Oct 28;17(10):e31103. doi: 10.5812/ircmj.31103. eCollection 2015 Oct. PMID: 26566455; PMCID: PMC4636855.
Copy Download .nbib Format: NLM
Coenzyme Q10 Supplementation Modulates NFκB and Nrf2 Pathways in Exercise Training.

Journal of sports science & medicine

Pala R, Orhan C, Tuzcu M, Sahin N, Ali S, Cinar V, Atalay M, Sahin K.
PMID: 26957943
J Sports Sci Med. 2016 Feb 23;15(1):196-203. eCollection 2016 Mar.

This study reports the effects of Q10, coenzyme Q10 or ubiquinone, a component of the electron transport chain in mitochondria, on nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), inhibitors of kappa B (IκB), nuclear factor (erythroid-derived 2)-like 2...

Cite
Pala R, Orhan C, Tuzcu M, et al. Coenzyme Q10 Supplementation Modulates NFκB and Nrf2 Pathways in Exercise Training. J Sports Sci Med. 2016;15(1):196-203
Pala, R., Orhan, C., Tuzcu, M., Sahin, N., Ali, S., Cinar, V., Atalay, M., & Sahin, K. (2016). Coenzyme Q10 Supplementation Modulates NFκB and Nrf2 Pathways in Exercise Training. Journal of sports science & medicine, 15(1), 196-203.
Pala, Ragip, et al. "Coenzyme Q10 Supplementation Modulates NFκB and Nrf2 Pathways in Exercise Training." Journal of sports science & medicine vol. 15,1 (2016): 196-203.
Pala R, Orhan C, Tuzcu M, Sahin N, Ali S, Cinar V, Atalay M, Sahin K. Coenzyme Q10 Supplementation Modulates NFκB and Nrf2 Pathways in Exercise Training. J Sports Sci Med. 2016 Feb 23;15(1):196-203. eCollection 2016 Mar. PMID: 26957943; PMCID: PMC4763840.
Copy Download .nbib Format: NLM
Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2).

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Atalay F, Ateşoğlu EB.
PMID: 26855506
Indian J Hematol Blood Transfus. 2016 Mar;32(1):46-53. doi: 10.1007/s12288-015-0509-2. Epub 2015 Feb 01.

Only one-third of elderly (>60 years) AML and MDS-RAEB2 patients may receive intensive chemotherapy treatment alternatives that are limited in this patient group due to the potential of severe toxicity. Previous studies have shown that azacitidine and low dose...

Cite
Atalay F, Ateşoğlu EB. Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2). Indian J Hematol Blood Transfus. 2015;32(1):46-53doi: 10.1007/s12288-015-0509-2.
Atalay, F., & Ateşoğlu, E. B. (2016). Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2). Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 32(1), 46-53. https://doi.org/10.1007/s12288-015-0509-2
Atalay, Figen, and Ateşoğlu, Elif Birtaş. "Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2)." Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion vol. 32,1 (2016): 46-53. doi: https://doi.org/10.1007/s12288-015-0509-2
Atalay F, Ateşoğlu EB. Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2). Indian J Hematol Blood Transfus. 2016 Mar;32(1):46-53. doi: 10.1007/s12288-015-0509-2. Epub 2015 Feb 01. PMID: 26855506; PMCID: PMC4733667.
Copy Download .nbib Format: NLM
Does the removal of spinal implants reduce back pain?.

Journal of clinical medicine research

Ak H, Gulsen I, Atalay T, Gencer M.
PMID: 25883710
J Clin Med Res. 2015 Jun;7(6):460-3. doi: 10.14740/jocmr2141w. Epub 2015 Apr 08.

BACKGROUND: The importance of the removal of spinal implants is known in the presence of infection. However, the benefits and/or risks of the removal of spinal implant for the management of back pain are not clear.METHODS: In this retrospective...

Cite
Ak H, Gulsen I, Atalay T, et al. Does the removal of spinal implants reduce back pain?. J Clin Med Res. 2015;7(6):460-3doi: 10.14740/jocmr2141w.
Ak, H., Gulsen, I., Atalay, T., & Gencer, M. (2015). Does the removal of spinal implants reduce back pain?. Journal of clinical medicine research, 7(6), 460-3. https://doi.org/10.14740/jocmr2141w
Ak, Hakan, et al. "Does the removal of spinal implants reduce back pain?." Journal of clinical medicine research vol. 7,6 (2015): 460-3. doi: https://doi.org/10.14740/jocmr2141w
Ak H, Gulsen I, Atalay T, Gencer M. Does the removal of spinal implants reduce back pain?. J Clin Med Res. 2015 Jun;7(6):460-3. doi: 10.14740/jocmr2141w. Epub 2015 Apr 08. PMID: 25883710; PMCID: PMC4394920.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 379 entries